Pharmacokinetics and safety of dasatinib and its generic: a phase I bioequivalence study in healthy Chinese subjects.

Yanli Wang,Jinling Xue,Zhengjie Su,Yingzi Cui,Guangwen Liu,Wei Yang,Zhengzhi Liu,Jiahui Chen,Qing Ren,Shuang Yu,Yang Cheng,Yannan Zhou,Wanhua Wang,Xuesong Chen,Dongmei Qu,Qiaohuan Deng,Yicheng Zhao,Haimiao Yang

Expert opinion on investigational drugs（2023）

引用 1|浏览7

暂无评分

摘要

This trial was registered in ClinicalTrials.gov (Number: NCT05640804) and Drug Clinical Trial Registration and Information Disclosure Platform (Number: CTR20181708).

查看译文

关键词

Bioequivalence,chronic myeloid leukemia,dasatinib,pharmacokinetics,safety

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要